These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16731104)

  • 21. Coagulation defects in neonates during cardiopulmonary bypass.
    Jobes DR; Nicolson SC; Steven JM; Manno CS
    Ann Thorac Surg; 1993 May; 55(5):1283-4. PubMed ID: 8338580
    [No Abstract]   [Full Text] [Related]  

  • 22. High-dose aprotinin, blood product transfusions, and short-term outcome in neonates and infants: a pediatric cardiac surgery center experience.
    Bojan M; Boulat C; Peperstraete H; Pouard P
    Paediatr Anaesth; 2012 Aug; 22(8):818-25. PubMed ID: 22416677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current and future trends in coagulation management for congenital heart surgery.
    Gottlieb EA; Andropoulos DB
    J Thorac Cardiovasc Surg; 2017 Jun; 153(6):1511-1515. PubMed ID: 28314527
    [No Abstract]   [Full Text] [Related]  

  • 24. Massive transfusion coagulopathy.
    Levy JH
    Semin Hematol; 2006 Jan; 43(1 Suppl 1):S59-63. PubMed ID: 16427387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenges for providing effective hemostasis in surgery and trauma.
    Lawson JH; Murphy MP
    Semin Hematol; 2004 Jan; 41(1 Suppl 1):55-64. PubMed ID: 14872423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery.
    Breuer T; Martin K; Wilhelm M; Wiesner G; Schreiber C; Hess J; Lange R; Tassani P
    Eur J Cardiothorac Surg; 2009 Jan; 35(1):167-71; author reply 171. PubMed ID: 19027313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Procedure for critical nonsurgical bleeding].
    Grottke O; Rossaint R
    Chirurg; 2007 Feb; 78(2):101-2, 104-9. PubMed ID: 17265055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Blood coagulation and fibrinolytic enzyme systems during and after extracorporeal circulation].
    Goldschmidt B; Böröcz L; Haas M; Büky B
    Thoraxchir Vask Chir; 1970 Dec; 18(6):510-9. PubMed ID: 5275551
    [No Abstract]   [Full Text] [Related]  

  • 29. [Efficacy of recombinant activated factor VII for treatment of life-threatening bleeding in cardiac surgery].
    Hamdani M; Bouzguenda H; Jebali MA; Ferjani M; Ziadi M; Chenik S
    Ann Fr Anesth Reanim; 2007; 26(7-8):712-4. PubMed ID: 17574372
    [No Abstract]   [Full Text] [Related]  

  • 30. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
    Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
    Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of bypass temperature on the systemic inflammatory response and organ injury after pediatric open surgery: a randomized trial.
    Stocker CF; Shekerdemian LS; Horton SB; Lee KJ; Eyres R; D'Udekem Y; Brizard CP
    J Thorac Cardiovasc Surg; 2011 Jul; 142(1):174-80. PubMed ID: 21420106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of recombinant factor VIIa in infants with severe coagulopathy.
    Fontaine MJ; Lazarchick J; Taylor S; Annibale D
    J Perinatol; 2004 May; 24(5):310-1. PubMed ID: 15116125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does aprotinin influence the inflammatory response to cardiopulmonary bypass in patients?
    Schmartz D; Tabardel Y; Preiser JC; Barvais L; d'Hollander A; Duchateau J; Vincent JL
    J Thorac Cardiovasc Surg; 2003 Jan; 125(1):184-90. PubMed ID: 12539003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin-coated bypass circuits: effects on inflammatory response in pediatric cardiac operations.
    Schreurs HH; Wijers MJ; Gu YJ; van Oeveren W; van Domburg RT; de Boer JH; Bogers AJ
    Ann Thorac Surg; 1998 Jul; 66(1):166-71. PubMed ID: 9692458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors influencing neurologic outcome after neonatal cardiopulmonary bypass: what we can and cannot control.
    Hsia TY; Gruber PJ
    Ann Thorac Surg; 2006 Jun; 81(6):S2381-8. PubMed ID: 16731107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemistry of serine protease inhibitors and their mechanisms of action: a review.
    Wegner J
    J Extra Corpor Technol; 2003 Dec; 35(4):326-38. PubMed ID: 14979425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current strategies for optimizing the use of cardiopulmonary bypass in neonates and infants.
    Shen I; Giacomuzzi C; Ungerleider RM
    Ann Thorac Surg; 2003 Feb; 75(2):S729-34. PubMed ID: 12607719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapy of acquired hemorrhagic diatheses].
    Heene D; Schultis K
    Med Welt; 1968 Apr; 15():985-7. PubMed ID: 5305016
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of recombinant factor VIIa for bleeding in paediatric practice.
    Millar CG; Stringer MD; Sugarman I; Richards M
    Haemophilia; 2005 Mar; 11(2):171-4. PubMed ID: 15810920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of recombinant factor VIIa in a preterm infant with coagulopathy and subdural hematoma.
    Altuncu E; Berrak S; Bilgen H; Yurdakul Z; Canpolat C; Ozek E
    J Matern Fetal Neonatal Med; 2007 Aug; 20(8):627-9. PubMed ID: 17674281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.